Exploring NVC-422: A Robust N-Chlorotaurine Analog with Potent Antimicrobial and Cytotoxic Profiles

3 June 2024
Neutrophils produce hypochlorous acid (HOCl) during the oxidative burst to combat invading pathogens, and the reaction of excess HOCl with taurine leads to the formation of N-chlorotaurine (NCT), an antimicrobial agent. NCT can be further modified under certain conditions to form N,N-dichlorotaurine (NNDCT). The study introduces NVC-422, a stabilized form of N-chlorotaurine derived from 2,2-dimethyltaurine, and examines its chemical properties, antimicrobial effectiveness, and cytotoxicity.

NVC-422 demonstrated potent antimicrobial activity against a range of microbial strains, including antibiotic-resistant Staphylococcus aureus and Enterococcus faecium. The compound showed a broad-spectrum efficacy with minimum bactericidal concentrations effective against both Gram-negative and Gram-positive bacteria. Against Candida species, the minimum fungicidal concentrations were also determined.

In vitro cytotoxicity tests revealed that NVC-422 has a similar toxicity profile to NNDCT, with a 50% cytotoxicity level comparable to that of NNDCT. The compound displayed rapid, pH-dependent antimicrobial action, with complete eradication of Escherichia coli and S. aureus within minutes at a specific concentration.

In a rat model of E. coli-infected granulating wounds, NVC-422 treatment significantly reduced bacterial loads and accelerated wound healing, suggesting its potential as a topical antimicrobial agent. The study's findings indicate the promise of NVC-422 in treating microbial infections and its potential application in wound care.

How to Use Synapse Database to Search and Analyze Translational Medicine Data?

The transational medicine section of the Synapse database supports searches based on fields such as drug, target, and indication, covering the T0-T3 stages of translation. Additionally, it offers a historical conference search function as well as filtering options, view modes, translation services, and highlights summaries, providing you with a unique search experience.

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

Taking obesity as an example, select "obesity" under the indication category and click search to enter the Translational Medicine results list page. By clicking on the title, you can directly navigate to the original page.

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

By clicking the analysis button, you can observe that GLP-1R treatment for obesity has gained significant attention over the past three years, with preclinical research still ongoing in 2023. Additionally, there are emerging potential targets, such as GDF15, among others.

图片包含 应用程序

描述已自动生成

Click on the image below to go directly to the Translational Medicine search interface.

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成